MULTIPLE TRANSFER FACTOR IN COMPLEX THERAPY FOR URINARY- BLOOD DISEASES OF NEWBORNED CALVES

Authors

  • V. Skybitskyi National University of Bioresources and Nature Management Of Ukraine , National University of Bioresources and Nature Management Of Ukraine
  • Viktoriya Postoi National University of Bioresources and Nature Management Of Ukraine , National University of Bioresources and Nature Management Of Ukraine
  • G. Kozlovska National University of Bioresources and Nature Management Of Ukraine , National University of Bioresources and Nature Management Of Ukraine

Abstract

The methodology for obtaining the factor of cellular immunity
transfer – transfer factor (TF) from colostrum cells of sensitized donor animals
is characterized in the paper, the results of the studying the preventive and
therapeutic efficacy of colostrum transfer factor of cellular immunity for
newborn calves' gastrointestinal diseases are described. In unfavorable
conditions of a farm, its positive effect has been experimentally proved in both
cases. The use of the transfer factor prevented the disease of animals. From
the 20 calves in the experimental group, only 12 were ill. The disease was
characterized by mild course. In the control group, where TF was not used, all
the animals and two calves were ill, despite intensive care, died.
Keywords:
transfer
factor,
colostrum,
newborn
calves,
gastrointestinal diseases

References

Andreev, E. V., Babkyn, A. F., Babkyn, V. F. i dr. (1985). Veterynarno-

sanytarnoe i tekhnolohycheskoe obespechenie profilaktiki i likvidatsii zabolevanii v

promyshlennom zhyvotnovodstve [Veterinary-sanitary and technological support for

the prevention and elimination of diseases in industrial animal husbandry]: Metod,

rekomendatsii. Kharkov,75.

Bezditko, L. V. (2008). Likuvalna efektyvnost kombiferonu pry shlunkovo-

kyshkovykh infektsiiakh u teliat [The therapeutic efficacy of combiferon in gastro-intestinal

infections in calves]. Zbirnyk naukovykh prats KhDZVA “Problemy zooinzhenerii ta

veterynarnoi medytsyny” Kh.: RVV KhDZVA. Vyp. 16 (41), T. 2. 50-54.

Lytvyn, V. P., Pozhyvyl, A. Y. (1992). Ynfektsyonnye i ynvazyonnne

bolezny teliat [Infectious and invasive calf diseases]:K.: Urozhai, 202.

Skybitskyi V. H. (2002). Etiopatohenez shlunkovo-kyshkovykh khvorob

novonarodzhenykh teliat ta taktyka borotby z nymy [Etiopathogenesis of gastrointestinal

diseases of newborn calves and tactics of struggle against them] : Veterynariia. No2. 21-

Stepaniuk O. V. (1999). Vlastyvosti faktora perenesennia aktyvnoho

imunitetu do zbudnyka Auiesky [Properties of active immunity transfer factor to

Auyeca causative agent]: Veterynarna medytsyna Ukrainy. No 9. 20-22.

Stoliuk, V. V. (2003). Otrymannia transfer-faktoru antyrabichnoho ta yoho

imunobiolohichni vlastyvosti [Obtaining transfection factor anti-rabies and its

immunobiological properties ] : avtoref. dys... kand. vet. nauk: 16.00.03 Nats. ahrar. un-t.

K., 21.

Tashuta O.S., Tashuta S.H. (2008). Efektyvnist klinichnoho zastosuvannia

eksperymentalnykh zrazkiv transfer-faktora dlia likuvannia khvorykh sobak

[Effectiveness of clinical application of experimental samples of transfer factor for the

treatment of sick dogs]:Tezy dopovidei konferentsii prof.vykl. skladu, nauk.

spivrobitnykiv i aspirantiv NNI veterynarnoi medytsyny ta yakosti i bezpeky produktsii

tvarynnytstva. Kyiv, 11– 12 bereznia . Kyiv, NAU.

Shyvinda Eduardo A. B., Kozlovska H. V. (1998). Pro induktsiiu

spetsyfichnoi rezystentnosti ta inshykh faktoriv imunitetu za dopomohoiu DEL [About

the induction of specific resistance and other immunity factors with the help of DEL] :

Veterynarna medytsyna Ukrainy. No7. 14-15.

Arnaudov, A., Tziporkov, N. (1995). Some properties and protective

activity of specific DLE against Salmonella cholera suis infection. Abstracts of the

communications presented at the Xth International symposium on transfer factor in

Bologna, 1995, 287-298.

Fazio, M., Camevale-Schianca, F., Sabidussi, A. (l995). Serial in vitro

transfer of hypersensitivity to cancer antigens by sensitised lymphocytes.

Panminerva med., 37, 386-389.

Fazio, M., Negri, L., Mostromatteo, V. (1987). Osteosarcoma - specific

transfer factor: preliminary clinical results. Exp. Pathol., 3, 4, 250-254.

Goldenberg, G. J., Brandes, L. J, Lau, W. H., et al. (1985). Cooperative

trial of immunitherapy for nasopharyngeal carcimoma with transfer factor from donors

with Epstein-Ban-virus antibody activity. Cancer Treat. Rep.,.69, 7-8, 761-767.

Mikula, I. (1993), Dialyzable leukocyte extract used in the prevention of

Salmonella infection in calves, Vet. Immunol, and Immunopathol., 32, 1/2, 113-124.

Mikula, I. (1993). Stabilization of Salmonella-specific dialyzable leukocyte

extracts. Vet. Immunol, and lmmunopathol, .32, 1/2, 103-112.

Pizza, G., Viza, D., Corrado, F. (1997). Effects of in vitro produces transfer

factor on the immune respons of cancer patients. Eur. J. Cancer., 13, .917-923.

Viza, D., Vich, I., Philips, I. (1987). Use specific transfer factor for the

prevention or the treatment of herpes infection in mice and man. Exp. Pathol, 3, 407-420.

Wesley, A., Dunnick, I., Fritz, H. (1976). Specifity and structural analysis of

a guinea pig Transfer Factor-like activity. lmmunology, 18, 1944-1950.

Wilson, G., Fudenberg, H. (1981). Leukocyte migration inhibition as a

method of assaying of transfer activities. Lymphokines, 4, 107.

Downloads

Published

2019-02-20

Issue

No. 293 (2018)

Section

Article

License

Relationship between right holders and users shall be governed by the terms of the license Creative Commons  Attribution – non-commercial – Distribution On Same Conditions 4.0 international (CC BY-NC-SA 4.0):https://creativecommons.org/licenses/by-nc-sa/4.0/deed.uk

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).